Clinico-pathological profile of patients with plasma cell neoplasms with special reference to bone marrow fibrosis and amyloid deposition

• Published in: Journal of Clinical and Experimental Hematopathology 2023/12/26, Vol.63(4), pp.214-218
• Main Authors: Kannan, Narasimhapriyan, Dass, Jasmita, Dangudubiyyam, Sahitya, Viswanathan, Ganesh Kumar, Aggarwal, Mukul, Kumar, Pradeep, Dhawan, Rishi, Seth, Tulika, Mahapatra, Manoranjan
• Format: Article
• Language: English
• Subjects: amyloid; fibrosis; myeloma; Original; plasma cell neoplasm; plasma cells
• ISSN: 1346-4280; 1880-9952
• DOI: 10.3960/jslrt.23029

To clarify the significance of bone marrow fibrosis and amyloid deposition in plasma cell neoplasm, a retrospective cross-sectional study for a period of 3 years was conducted. Patients who underwent bone marrow aspiration and biopsy with suspicion of plasma cell neoplasms were included in the study. The bone marrow findings were correlated with clinical profile of the patient along with biochemical parameters, cytogenetics, Fluorescent in situ hybridization (FISH) wherever available. A total of 273 bone marrow aspirates and biopsies of patients with suspected plasma cell neoplasms were analyzed. There were 181 male patients and 92 female patients (Male: Female = 1.96: 1). There were 245 cases of multiple myeloma (89.7%), 8 cases of primary amyloidosis (2.9%) and 6 monoclonal gammopathy of undetermined significance (MGUS) (2.1%), 5 cases of plasmacytoma (1.8%) and 4 cases of smouldering myeloma (1.4%), 5 cases of POEMS syndrome (1.8%). Bone marrow fibrosis was noted in 12 patients at diagnosis (4.3%). Among the parameters studied, only the mean Hemoglobin was significantly low in patients with marrow fibrosis. Amyloid deposition in various organs including bone marrow, kidney, liver etc., were noted in 17 patients overall (6.2%). In conclusion, the incidence of fibrosis (4.3%) and amyloidosis (6.2%) associated with plasma cell neoplasms were much lower in our study as compared to published studies.